COREX SUPPORT SERVICES FOR RARE DISEASES

What Is a Named Patient Programme?

A Named Patient Programme allows a doctor to request access to a medicine on behalf of an individual patient when:

No authorised alternative is available in their country
The product is authorised elsewhere or in late-stage trials
The patient has a serious or rare condition
The need is urgent and well justified clinically

In this case, regulators may grant special import permission for a limited quantity of the medicine, strictly for personal use.

How it works

Our regulatory team coordinates with manufacturers and health authorities to secure import permits, manage compliant storage, and arrange direct delivery to patients within approved timelines.

Problem:

Individual patients with serious conditions need access to medicines not yet approved locally.

Solution

A Named Patient Programme enables doctors to request unauthorised medicines for individual patients when no approved alternative exists locally, the product is authorised elsewhere or in late-stage trials, the patient has a serious or rare condition, and the clinical need is urgent and well justified.

How COREX Supports NPP Access

Sourcing & Importation of Unlicensed Medicines

Regulatory Consultation & Country-Specific Compliance

Secure Cold Chain Storage & Distribution

Documentation Management & Product Traceability

Collaboration with Healthcare Professionals (HCPs) and Ministries of Health (MoH)

Contact Our Team

Why NPP Access Matters

For patients facing life-threatening conditions with no other
treatment options, time is critical. NPPs provide a legal and ethical
pathway to receive potentially life-saving therapy — when
clinical trials are not accessible or marketing authorisation
is not yet granted.